Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phoenix Pharmaceuticals is a specialized biotechnology company focused on the development and supply of high-quality peptides, antibodies, and diagnostic kits for biomedical research. The company offers an extensive catalog of over 7,000 products, including bioactive peptides, enzyme immunoassay (EIA) kits, radioimmunoassay (RIA) kits, and fluorescent immunoassay (FEIA) kits. Their expertise spans across various physiological systems, with a particular emphasis on obesity, diabetes, cardiovascular health, and neuroscience. Phoenix Pharmaceuticals serves as a critical partner for academic and industrial researchers by providing standardized reagents for the detection and quantification of neuropeptides and metabolic hormones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Peptide.